BI
AMGN icon

Bolthouse Investments’s Amgen AMGN Stock Holding History

Bolthouse Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Hold
1,850
– – 0.59% 34
2025
Q4 		$605K Hold
1,850
– – 0.54% 38
2025
Q3 		$522K Hold
1,850
– – 0.47% 43
2025
Q2 		$517K Hold
1,850
– – 0.51% 41
2025
Q1 		$576K Hold
1,850
– – 0.6% 37
2024
Q4 		$482K Buy
+1,850
New +$549K 0.45% 49

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bolthouse Investments's AMGN Position: Q1 2026 in Review

Bolthouse Investments held its Amgen (AMGN) position steady in Q1 2026 at 1,850 shares worth $651K. The position accounts for 0.59% of the portfolio, ranked #34.

Bolthouse Investments first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bolthouse Investments held 1,850 shares of Amgen worth $651K as of Q1 2026.
  • Bolthouse Investments left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.59% of Bolthouse Investments's portfolio in Q1 2026, its #34 holding.
  • Bolthouse Investments first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bolthouse Investments's 13F filing for Q1 2026, filed 28 Apr 2026.